ABSTRACT- Objective: To assess the epilepsy treatment gap in Campinas and São José do Rio Preto, two cities in the State of São Paulo, Brazil. Method: The treatment gap was estimated using the formula n1-n2/n1x100, where n1 was calculated using 1.86 % prevalence and represented the number of individuals with epilepsy, while n2 represented the number of people who could be treated with an adult standard dose for a year utilizing the antiepileptic drugs supplied by the public health system. Results: Our esti-mates revealed that in 2001, approximately 50 % of the population with epilepsy was treated with the rec-ommended antiepileptic medication. Conclusion: These results suggest that a relevant percentage of patients with epilepsy are not unt...
International audienceBackground: The World Health Organization estimates that 50 million people wor...
Objective World Health Organization (WHO) estimates 8/1.000 individuals worldwide suffer from epilep...
Epilepsy is the most prevalent non-communicable serious neurological condition worldwide. Unfortunat...
OBJECTIVE: To assess the epilepsy treatment gap in Campinas and São José do Rio Preto, two cities in...
To assess the epilepsy treatment gap in Campinas and São Josédo Rio Preto, two cities in the State o...
Purpose: The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access...
SUMMARY: In many developing countries, people with epilepsy do not receive appropriate treatment for...
The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access to treat...
To provide a situation assessment of services for people with epilepsy in the context of primary hea...
International audiencePurpose: To report epidemiological data from a crosssectionaldoortodoorsurvey ...
PURPOSE: To provide a situation assessment of services for people with epilepsy in the context of pr...
Orientador: Li Li MinTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Med...
Epilepsy is a frequent condition in the world. Recently a study in Brazil showed prevalence of 18/10...
International audienceABSTRACTObjective World Health Organization (WHO) estimates 8/1.000 individual...
Abstract – Purpose: To assess the perception of epilepsy stigma in different regions of Brazil. Meth...
International audienceBackground: The World Health Organization estimates that 50 million people wor...
Objective World Health Organization (WHO) estimates 8/1.000 individuals worldwide suffer from epilep...
Epilepsy is the most prevalent non-communicable serious neurological condition worldwide. Unfortunat...
OBJECTIVE: To assess the epilepsy treatment gap in Campinas and São José do Rio Preto, two cities in...
To assess the epilepsy treatment gap in Campinas and São Josédo Rio Preto, two cities in the State o...
Purpose: The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access...
SUMMARY: In many developing countries, people with epilepsy do not receive appropriate treatment for...
The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access to treat...
To provide a situation assessment of services for people with epilepsy in the context of primary hea...
International audiencePurpose: To report epidemiological data from a crosssectionaldoortodoorsurvey ...
PURPOSE: To provide a situation assessment of services for people with epilepsy in the context of pr...
Orientador: Li Li MinTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Med...
Epilepsy is a frequent condition in the world. Recently a study in Brazil showed prevalence of 18/10...
International audienceABSTRACTObjective World Health Organization (WHO) estimates 8/1.000 individual...
Abstract – Purpose: To assess the perception of epilepsy stigma in different regions of Brazil. Meth...
International audienceBackground: The World Health Organization estimates that 50 million people wor...
Objective World Health Organization (WHO) estimates 8/1.000 individuals worldwide suffer from epilep...
Epilepsy is the most prevalent non-communicable serious neurological condition worldwide. Unfortunat...